To display releases by year, please select a year below and click Filter.
March 12, 2026
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor
View Press Release
March 2, 2026
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
View Press Release
February 24, 2026
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
View Press Release
February 19, 2026
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
View Press Release
February 19, 2026
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
View Press Release
February 16, 2026
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results
View Press Release
January 29, 2026
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
View Press Release
December 15, 2025
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
View Press Release
December 1, 2025
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
View Press Release
November 18, 2025
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
View Press Release
Displaying 1 - 10 of 116